SCHEMBL17781808

SCHEMBL17781808

C=C(OCC)c1c([C@@H]2CC[C@](OCCOC)(C(=O)O)C(C(C)OC)C2)nc2c(-c3ccc(-c4ccn(C)n4)nc3)cnn2c1N(COCC[Si](C)(C)C)COCC[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17781809 0.92 DGAT1 (0.30) —
SCHEMBL17781810 0.90 DGAT1 (0.30) —
SCHEMBL15007135 0.87 DGAT1 (0.31) —
SCHEMBL15007519 0.87 DGAT1 (0.31) —
SCHEMBL15026301 0.87 DGAT1 (0.31) —
SCHEMBL17781813 0.85 DGAT1 (0.31) —
SCHEMBL14298292 0.82 DGAT1 (0.32) —
SCHEMBL17781811 0.81 DGAT1 (0.31) —
SCHEMBL17836468 0.81 DGAT1 (0.36) —
SCHEMBL15007268 0.80 DGAT1 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2608668-B1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN MERCK SHARP & DOHME (US) 2016-06-01 — — EP disclosed
Send feedback